Ondine Cash And Short Term Investments vs Total Current Liabilities Analysis

OBI Stock   8.25  0.12  1.48%   
Ondine Biomedical financial indicator trend analysis is much more than just breaking down Ondine Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ondine Biomedical is a good investment. Please check the relationship between Ondine Biomedical Cash And Short Term Investments and its Total Current Liabilities accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Cash And Short Term Investments vs Total Current Liabilities

Cash And Short Term Investments vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ondine Biomedical Cash And Short Term Investments account and Total Current Liabilities. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Ondine Biomedical's Cash And Short Term Investments and Total Current Liabilities is -0.39. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Ondine Biomedical, assuming nothing else is changed. The correlation between historical values of Ondine Biomedical's Cash And Short Term Investments and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Ondine Biomedical are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash And Short Term Investments i.e., Ondine Biomedical's Cash And Short Term Investments and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

-0.39
Relationship DirectionNegative 
Relationship StrengthInsignificant

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Ondine Biomedical balance sheet. This account contains Ondine Biomedical investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Ondine Biomedical fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Total Current Liabilities

Total Current Liabilities is an item on Ondine Biomedical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ondine Biomedical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Ondine Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ondine Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ondine Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The current year's Issuance Of Capital Stock is expected to grow to about 9.1 M, whereas Selling General Administrative is forecasted to decline to about 7.8 M.
 2021 2022 2023 2024 (projected)
Interest Expense1.2M30K38K36.1K
Depreciation And Amortization514K493K587K517.3K

Ondine Biomedical fundamental ratios Correlations

-0.390.790.32-0.82-0.510.531.0-0.45-0.211.00.24-0.29-0.080.44-0.381.0-0.450.330.9-0.460.67-0.34-0.20.170.7
-0.39-0.87-0.090.850.07-0.47-0.380.1-0.33-0.390.280.510.290.051.0-0.390.990.34-0.240.99-0.40.17-0.360.36-0.3
0.79-0.870.21-0.99-0.290.590.78-0.290.110.79-0.08-0.48-0.230.17-0.860.78-0.89-0.060.62-0.890.63-0.270.13-0.130.57
0.32-0.090.21-0.29-0.660.120.36-0.74-0.040.370.45-0.06-0.120.79-0.070.38-0.160.620.33-0.170.55-0.8-0.070.070.66
-0.820.85-0.99-0.290.35-0.6-0.810.38-0.11-0.82-0.020.50.23-0.260.83-0.820.88-0.04-0.670.88-0.650.36-0.130.13-0.62
-0.510.07-0.29-0.660.35-0.66-0.490.510.66-0.5-0.56-0.280.02-0.90.05-0.540.16-0.6-0.670.17-0.790.420.63-0.57-0.85
0.53-0.470.590.12-0.6-0.660.5-0.28-0.420.510.240.01-0.110.44-0.470.53-0.530.070.68-0.530.64-0.13-0.430.410.69
1.0-0.380.780.36-0.81-0.490.5-0.52-0.151.00.27-0.33-0.080.46-0.361.0-0.430.360.89-0.440.65-0.4-0.150.130.7
-0.450.1-0.29-0.740.380.51-0.28-0.52-0.21-0.52-0.730.490.02-0.790.08-0.530.18-0.6-0.610.19-0.260.96-0.20.2-0.51
-0.21-0.330.11-0.04-0.110.66-0.42-0.15-0.21-0.15-0.2-0.78-0.07-0.38-0.34-0.18-0.28-0.34-0.33-0.28-0.53-0.350.98-0.91-0.47
1.0-0.390.790.37-0.82-0.50.511.0-0.52-0.150.28-0.34-0.080.47-0.371.0-0.440.360.9-0.450.65-0.41-0.140.120.7
0.240.28-0.080.45-0.02-0.560.240.27-0.73-0.20.28-0.06-0.110.770.30.30.180.830.560.170.16-0.62-0.180.130.36
-0.290.51-0.48-0.060.5-0.280.01-0.330.49-0.78-0.34-0.060.120.00.51-0.330.50.23-0.270.50.270.56-0.840.860.18
-0.080.29-0.23-0.120.230.02-0.11-0.080.02-0.07-0.08-0.110.12-0.010.28-0.080.290.0-0.080.29-0.10.07-0.080.08-0.07
0.440.050.170.79-0.26-0.90.440.46-0.79-0.380.470.770.0-0.010.070.5-0.050.720.67-0.060.54-0.73-0.340.270.7
-0.381.0-0.86-0.070.830.05-0.47-0.360.08-0.34-0.370.30.510.280.07-0.370.990.36-0.230.99-0.390.15-0.360.36-0.28
1.0-0.390.780.38-0.82-0.540.531.0-0.53-0.181.00.3-0.33-0.080.5-0.37-0.450.370.91-0.450.67-0.42-0.170.140.72
-0.450.99-0.89-0.160.880.16-0.53-0.430.18-0.28-0.440.180.50.29-0.050.99-0.450.24-0.331.0-0.470.23-0.310.32-0.38
0.330.34-0.060.62-0.04-0.60.070.36-0.6-0.340.360.830.230.00.720.360.370.240.460.230.44-0.51-0.370.370.55
0.9-0.240.620.33-0.67-0.670.680.89-0.61-0.330.90.56-0.27-0.080.67-0.230.91-0.330.46-0.330.58-0.45-0.280.210.69
-0.460.99-0.89-0.170.880.17-0.53-0.440.19-0.28-0.450.170.50.29-0.060.99-0.451.00.23-0.33-0.480.24-0.310.31-0.39
0.67-0.40.630.55-0.65-0.790.640.65-0.26-0.530.650.160.27-0.10.54-0.390.67-0.470.440.58-0.48-0.19-0.570.570.95
-0.340.17-0.27-0.80.360.42-0.13-0.40.96-0.35-0.41-0.620.560.07-0.730.15-0.420.23-0.51-0.450.24-0.19-0.350.36-0.4
-0.2-0.360.13-0.07-0.130.63-0.43-0.15-0.20.98-0.14-0.18-0.84-0.08-0.34-0.36-0.17-0.31-0.37-0.28-0.31-0.57-0.35-0.98-0.53
0.170.36-0.130.070.13-0.570.410.130.2-0.910.120.130.860.080.270.360.140.320.370.210.310.570.36-0.980.55
0.7-0.30.570.66-0.62-0.850.690.7-0.51-0.470.70.360.18-0.070.7-0.280.72-0.380.550.69-0.390.95-0.4-0.530.55
Click cells to compare fundamentals

Ondine Biomedical Account Relationship Matchups

Ondine Biomedical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.9M2.6M34.1M16.6M5.7M9.0M
Total Current Liabilities28.7M35.8M3.9M3.9M3.5M3.3M
Total Stockholder Equity(26.1M)(33.8M)29.7M11.6M2.1M2.2M
Property Plant And Equipment Net849K671K601K1.4M949K663.6K
Net Debt27.7M30.8M(29.6M)(12.2M)(2.4M)(2.3M)
Retained Earnings(165.9M)(182.1M)(232.5M)(251.9M)(266.3M)(253.0M)
Accounts Payable183K237K1.2M388K1.4M923.0K
Cash306K626K30.4M13.1M3.0M4.5M
Non Current Assets Total1.9M888K636K1.4M984K1.3M
Non Currrent Assets Other42K40K46K35K36K33.3K
Cash And Short Term Investments306K626K30.4M13.1M3.0M5.6M
Net Receivables24K543K248K133K220K269.6K
Liabilities And Stockholders Equity2.9M2.6M34.1M16.6M5.7M9.0M
Non Current Liabilities Total316K678K561K1.0M159K151.1K
Other Stockholder Equity20.3M28.8M27.2M28.5M28.8M33.0M
Total Liab29.0M36.5M4.5M4.9M3.6M3.5M
Total Current Assets1.0M1.7M33.5M15.1M4.8M7.7M
Short Long Term Debt Total28.0M31.5M739K896K541K514.0K
Other Current Liab760K4.2M2.1M3.2M1.7M1.0M
Other Current Assets236K717K2.1M710K703K1.1M
Short Term Debt27.7M31.4M645K359K382K362.9K
Inventory468K404K1.1M1.3M1.1M646.2K
Capital Lease Obligations569K310K242K896K541K469.7K
Net Invested Capital1.4M334K30.2M11.6M2.1M2.0M
Net Working Capital(27.7M)(34.0M)29.6M11.2M1.3M1.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ondine Stock

Balance Sheet is a snapshot of the financial position of Ondine Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Ondine Biomedical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ondine Biomedical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ondine currently owns. An asset can also be divided into two categories, current and non-current.